Esperion Therapeutics
ESPR
#6609
Rank
โ‚น78.85 B
Marketcap
โ‚น306.00
Share price
0.00%
Change (1 day)
208.17%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น74.13 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚น74.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น68.92 B9.69%
2024-12-31โ‚น62.84 B14.24%
2023-12-31โ‚น55.01 B16.28%
2022-12-31โ‚น47.30 B9.87%
2021-12-31โ‚น43.06 B31.02%
2020-12-31โ‚น32.86 B136.96%
2019-12-31โ‚น13.86 B208.33%
2018-12-31โ‚น4.49 B112.56%
2017-12-31โ‚น2.11 B87.48%
2016-12-31โ‚น1.12 B104.33%
2015-12-31โ‚น0.55 B-10.34%
2014-12-31โ‚น0.61 B137.29%
2013-12-31โ‚น0.25 B-80.8%
2012-12-31โ‚น1.35 B210.41%
2011-12-31โ‚น0.43 B
2002-12-31โ‚น0.60 B6.28%
2001-12-31โ‚น0.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚น11.278 T 15,113.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น908.86 B 1,125.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น146.74 B 97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น6.34 B-91.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น65.01 B-12.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น228.91 B 208.76%๐Ÿ‡บ๐Ÿ‡ธ USA